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PREVALENCE AND CLINICAL CHARACTERISTICS OF NIGERIAN PATIENTS 
WITH EARLY-ONSET TYPE 2 DIABETES 
ABSTRACT
Background
The prevalence of early-onset type2 diabetes is increasing, and there are indications that the clinical characteristics may be different 
from late-onset type2 diabetes. The objective of this study was to determine the prevalence of early-onset T2D among the clinic 
population of a tertiary academic health centre in Nigeria and to describe and compare the clinical characteristics of early and late-
onset T2D.
Method
Demographic and clinical parameters were retrospectively retrieved from the case records of patients in the clinic registry of a 
diabetes clinic of an academic health institution. Patients with clinical T2D diagnosed =40 years (Early Onset T2D- ET2D) were 
compared with T2D patients diagnosed at >40 years (Late Onset T2D- LT2D). Data were captured and analysed using SPSS version 20. 
Categorical variables in the two groups were compared using Chi-Square, while continuous variables were compared using Student's 
t-test. 
Results
Out of 589 subjects with complete data, 256 (43.5%) were males and had a mean current age of 60.1 (11.6) years and median 
diabetes duration of 10.0 (IQR 14.7). Prevalence of subjects with early-onset diabetes in the cohort was 17%. Diabetes duration was 
longer in ET2D than LT2D {10 (IQR 14.8) versus 7.0 (8.0), p = 0.000}. Proportion of ET2D with poor glycaemic control was significantly 
higher compared to LT2D {54 (70.1) versus 204 (53.3), p = 0.007}. Also more ET2D were on insulin compared with LT2D {31 (33.0) 
versus 97 (20.8), p = 0.029}.
Conclusion
ET2D patients of this Nigerian population appear to be significantly different in some clinical profile from LT2D. This may imply a 
possible lifetime increase in microvascular complications and cardiovascular events in a productive age group of society.
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he incidence of type 2 diabetes (T2D), the 
commonest form of diabetes among youth and 
younger adults has increased dramatically in recent T
times(1)(2). The increasing rate of T2D among younger 
adults is a departure from the typical presentation in 
middle age and older adults. Additionally, the incidence 
and prevalence of T2D in youths and young adults vary 
depending on the races and ethnicities with the highest 
occurrence among African Americans (3). Amongst native 
black Africans, the proportion of adults with diabetes 
between 20-39 years has increased to about 40%(4). The 
significance of this rising incidence in Africa's most 
productive age group has not been well investigated. 
Evidence is accumulating that the course and outcome of 
management may be different depending on whether T2D 
occurs earlier or later in life (5) (6) (7) (8). Glycaemic control 
was worse in adults <65 years compared to adults 65 years 
and above(9). Earlier onset T2D impacted severity of 
retinopathy(10). Early-onset T2D has a lifetime risk of 
cardiovascular complications and this occurs at early stage 
of life than late-onset T2D(11)(12). Furthermore, mortality 
is substantially increased in patients with early-onset 
diabetes after the first vascular event(13). Therefore, these 
subjects have become a clinical priority for individualised 
care and aggressive measures to prevent microvascular 
and macrovascular complications in early stage of life.
It is not clear whether native Africans with early-onset T2D 
have different clinical profile compared to the late-onset 
subjects. In this study, we sought to determine the 
prevalence of early-onset T2D among the clinic population 
of a tertiary academic health centre in Nigeria and explore 
possible clinical differences between early and late-onset 
T2D.
Methodology
A retrospective study was carried out involving patients 
attending the diabetes clinic of the University College 
Hospital (UCH), Ibadan, Nigeria. Ethical permission was 
granted by the University of Ibadan and University 
College Hospital Joint Ethical Committee (UI/UCH Ethics 
Approval Number: UI/EC/18/0101). The UCH is an over 
800-bedded academic tertiary health institution and a key 
referral centre from the southwest zone of the country. 
Demographic and relevant clinical variables were 
extracted from a clinic registry compiled between 2009 and 
2010. Data were compared between all patients first 
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diagnosed as T2D at the age of 40 years or below (defined 
as early-onset T2D) and those first diagnosed as T2D above 
40 years of age (defined as late-onset T2D). Diagnosis of 
T2D was based on WHO 1999 criteria (14). Out of a total of 
735 subjects in the database compiled then and with 
complete relevant data, 589 were diagnosed as T2D, 34 as 
type1 diabetes (T1D), 8 as gestational diabetes mellitus 
(GDM) and the remaining 3 were unclassified. Other 
subjects, apart from T2D, were excluded from further 
analysis. Information on current age, gender, diabetes 
duration, diabetes and lipid treatment, body mass index 
(BMI) and blood pressure were obtained from the case 
records. The most current fasting plasma glucose (FPG) 
and 2-hour postprandial (2-HPP), as well as haemoglobin 
A1c, were also obtained. Relatively few patients had 
records of haemoglobin A1c results.
Data were entered into SPSS version 20 for analysis. 
Demographic and selected clinical characteristics of the 
early onset subjects were described and compared with 
those of the late-onset group. Continuous variables 
summarized as mean (SD), or median as appropriate and 
categorical variables summarised as frequency 
(percentage) were compared between early-onset and late-
onset subjects, using Student's t-test and Chi-Square test, 
respectively. Diabetes treatment was dichotomized into 
either use of oral glucose-lowering agents (OGLA) or 
insulin/insulin-containing regimen, and this was related 
to early and late-onset patients. The odd of using insulin 
was then determined between the two groups. The two 
age-onset categories were related to measures of glycaemic 
control using the blood glucose as well as the few available 
haemoglobin A1c results.  Good glycaemic control was 
considered as both FPG <130 mg/dl and 2-HPP <180 
mg/dl based on blood glucose only, and value =7% based 
on haemoglobin A1c. Association between glycaemic 
control and selected clinical parameters was determined 
using Chi-Square while logistic regression was performed 
to determine independent predictors of poor glycaemic 
control, the latter coded as an outcome variable of interest.
Results
Out of the 589 subjects, 256 (43.5%) were males, and 333 
(56.5%) were females. There was no significant difference 
in gender distribution between the early and late-onset 
patients (Table 1). The mean (SD) current age of early-onset 
subjects was 46.4 (9.0) years while that of late-onset was 
62.9 (10.0) years. Also, the mean age (SD) at diagnosis of 
both early and late-onset T2D were 34.2 (4.9) and 54.6 (9.2) 
respectively. A total of 100 (17.0%) had early-onset 
diabetes while 489 (83.0%) had late-onset diagnosis. 
Compared to the late-onset, early-onset subjects 
significantly had a longer duration of diabetes, higher 
plasma glucose and HbA1c and, though not statistically 
significant, higher BMI. There was no difference in the 
prevalence of early-onset subjects with BMI =25 compared 
to late-onset group {(85.0 (85.0) and 389 (79.6)}respectively. 
On the other hand, late-onset subjects significantly had 
higher systolic BP and the prevalence of hypertension. 













 Age at diagnosis in yrs. 34.2 (4.9) 54.6 (9.2)
 
0.000*
Sex n (%): Males
 










DM Duration in years 
(Median/IQR)
10.0 (14.75) 7.0 (8.0)
 
0.000**
Hypertensive n (%) 43 (53.1) 316 (77.1%) 0.000*
Systolic BP mmHg 126.9 (21.6) 133.4 (21.6) 0.008*




















208.0 (93.6) 190.8 (86.6) 0.128
HbA1c % 9.5 (1.3) 7.5 (2.3) 0.045*
On Anti-lipids n (%) 27 (34.2) 129 (31.9) 0.70
* Significant p-value using Student's t-test;  **Median comparison using Mann-Whitney U. Unless otherwise stated, values are 
mean (SD). DM= Diabetes. ET2D- Early Onset type2 diabetes; LT2D- Late-onset type2 diabetes. FPG= Fasting Plasma Glucose; 
2HPP= 2-hour postprandial
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Based on plasma glucose, the prevalence of subjects with 
poor glycaemic control was significantly higher in the 
early onset compared with late-onset T2D {54 (70.1) versus 
204 (53.3) respectively}. Similarly, based on haemoglobin 
A1c, all the 6 subjects with available test results in the early-
onset group had poor glycaemic control compared with 35 
(or 59.3%) of subjects with late-onset diagnosis (Table 3). 
As shown in Table 4, age of onset (less than 40 years and 40 
years and above) and duration of diabetes (less than 5 years 
and 5 years and above) were significantly associated with 
glycaemic control. The risk for poor glycaemic control was 
higher among subjects with early-onset diabetes, and those 
table 2 shows the distribution of subjects according to the type of hypoglycaemic agents used. The odd of patients with early-
onset being on insulin or insulin-containing regimen was 1.9. 
Table 2: Comparison of Proportions of Subjects Using OGLA and Insulin 
Types of Anti-hyperglycemic 
Treatment 
ET2D LT2D P-value 
Insulin 31 (33.0) 97 (20.8) 128 (22.9) 0.029*
No insulin 63 (67.0) 369 (79.2) 432 (87.1)
Total 94 (100) 466 (100) 560 (100)
*Significant p-value on Pearson Chi-Square test
 
Table 3: Comparison of Poor Glycaemic Control Between Early and Late T2D 
Measure of Glycaemic 
Control
ET2D LT2D Total P-value 
By Plasma Glucose 54 (70.1) 204 (53.3) 258 (56.1) 0.007*
0.089By Haemoglobin A1c
 
6 (100) 29 (54.7) 35 (59.3)
P-value on Chi-Square test 
 Table 4: Association Between Clinical Characteristics and Glycaemic Control of Participants
Characteristic Poor Control Good Control Chi-square P-value
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Discussion
In this study, to the best of our knowledge, we have 
described for the first time the characteristics of Nigerian 
subjects with early onset of T2D compared to those with 
late-onset disease and showed that the two groups were 
significantly different in certain clinical parameters. 
Prevalence of subjects with early-onset diabetes in the 
cohort was 100 (17%). Early-onset patients significantly 
had a longer duration of diabetes, had a poorer glycaemic 
control and were more likely to be on insulin or insulin-
containing treatment regimen. There were no significant 
Table 5: Predictors of Glycaemic Control Among Participants 
Predictor Odds Ratio Confidence Interval P-value 
Diabetes Duration 
 < 5 years 
 > 5 years 
1 
2.01 1.19 -3.46 
0.009* 
BMI 
   Normal 
 Overweight/Obese 
1 







1.30 – 3.08 0.001* 
*Significant
Figure 1
differences between the two groups in terms of 
cardiometabolic features such as BMI, blood pressure and 
use of lipid-lowering agents. Finally, age-onset of diabetes 
and duration of diabetes were significant independent 
predictors of glycaemic control in the subjects.
As inherent in most retrospective studies, there were 
limitations with complete data retrieval of selected 
variables. Also, the number of subjects with records of 
haemoglobin A1c results was small. This is not unusual in 
developing countries like Nigeria, where often there is 
disinclination by patients to do HbA1c, mainly because it is 
relatively more expensive than blood glucose. In Nigeria, 
health insurance coverage is very small; hence most 
patients pay out-of-pocket for healthcare. Furthermore, 
patients, many of whom are illiterate, don't appreciate the 
importance of HbA1c and relative superiority of the test for 
monitoring status of glycaemic control, even when 
attempts are made to explain its usefulness. Even then, our 
findings have shown that African patients whose onset of 
diabetes occurred at a younger age (= 40 years) had a 
different clinical profile from the typical T2D patients 
whose onset of disease occurred in the middle or old age. 
Although data is sparse, similar studies, using different cut 
off age such as 30, 35 or 40 years, reported prevalence rates 
of early onset (or young onset) T2D ranging between 11-
27.8% (15)(5)(6)(16)(7)(17). Our prevalence rate of 17% was 
very similar to the 18% reported in the JADE (Joint Asia 
Diabetes  Evaluat ion)  programme.  The JADE 
programme(6) was a large prospective study involving 245 
outpatient clinics in nine Asian countries, using 40 years 
age cut off for early-onset T2D participants. Our finding is 
however higher than 11% reported as the proportion of 
Nigerian T2D subjects first diagnosed between age-range 
30-39 years in a cross-section of clinic population at the 
University of Benin Teaching hospital (18). The 30 years 
lowest cut off age in the Benin study could account for the 
relatively lower proportion of young onset diabetes 
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patients.
Similar to our finding, the JADE study reported median 
diabetes duration of 10 years (IQR 3-18 years) in the early 
onset subjects, which was significantly higher than the late-
onset group {5 years (2-11 years)}. This is not unexpected 
considering the fact that those whose diabetes set in early 
are likely to have been in the clinic much longer than the 
late-onset subjects. Notably, both the current age and the 
age at diagnosis for both groups were significantly 
different.
Our study confirmed the observation by other 
researchers(19)(20)(21)(9) that higher proportions of early-
onset diabetes subjects usually have poorer glycaemic 
control compared to late-onset subjects.  Benhalima and 
colleagues (19) reported that 63% of their early-onset T2D 
study population still had A1c >7% after 3.2 years of follow 
up. This is lower than the finding of 100% in our early-onset 
group based on the few available HbA1c results. However, 
using blood glucose, the finding of 70.1% subjects with 
poor glycaemic control is lower is lower than 80.8% 
reported among Chinese population with early-onset 
T2D(21). Probably this is why a larger percentage of our 
early-onset patients were on insulin compared to the late-
onset. In 7844 adults in a Health Management Office, early-
onset subjects were 80% more likely to begin insulin 
treatment than the usual onset, with a hazard ratio of 1.8 
(95% Confidence Interval 1.5-2.0), despite the similar 
average time of 2.2 years to requiring insulin(16). We could 
not retrieve sufficient information to calculate time to 
insulin requirement in our study sample.
The longer duration of diabetes in the early onset T2D 
could have significantly contributed to the poor glycaemic 
control and consequent earlier commencement of insulin. 
Among 2733 T2D British subjects, Song and co-
workers(22) observed an increase in mean (SD) of HbA1c 
in those with diabetes duration between 10-20 years 
compared to <10 years duration. Additionally, T2D 
patients <40 years of age in each category of diabetes 
duration had relatively higher HbA1c. Perhaps the age 
onset of diabetes at diagnosis affects the state of ß Islet cells. 
Age at diagnosis has been shown to positively correlate 
with fasting C-peptide with a more rapid decline in ß-cell 
function in the very young patients(23).
Future prospective studies are needed to confirm our 
findings and to investigate their implications on the 
development of vascular complications in the subjects with 
T2D.  
In conclusion, the clinical and metabolic characteristics of 
these Nigerian subjects with earlier onset T2D appear to be 
significantly different from their counterparts with late-
onset. Notably, the early onset patients had a poorer 
glycaemic profile, which could portend a higher risk of 
microvascular and cardiovascular complications in the 
future. Interestingly, both groups had a similar 
distribution of cardiometabolic features. 
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